Brand
Vitruvias Therapeutics
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Vitruvias Therapeutics and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-08-21FDA-PRVitruvias Thyroid Tablets recalled for super potency risk
AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.
Get notified about new Vitruvias Therapeutics recalls
Free weekly digest. We email when a new federal recall affects Vitruvias Therapeutics or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state
Get alerts for your household